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Abstract—A role for the antioxidants vitamin E and idebenone in decreasing retinal cell injury, after metabolic
inhibition induced by chemical ischemia and hypoglycemia, was investigated and compared with oxidative stress
conditions. Preincubation of the antioxidants, vitamin E (20 mM) and idebenone (10 mM), effectively protected from
retinal cell injury after oxidative stress or hypoglycemia, whereas the protection afforded after postincubation of both
antioxidants was decreased. Delayed retinal cell damage, mediated by chemical ischemia, was attenuated at 10 or 12 h
postischemia, only after exposure to the antioxidants during all the experimental procedure. An antagonist of the
N-methyl-D-aspartate (NMDA) receptors, an inhibitor of nitric oxide synthase (NOS) or a blocker of L-type Ca21
channels were ineffective in reducing cell injury induced by chemical ischemia, hypoglycemia or oxidative stress.
Oxidative stress and hypoglycemia increased (about 1.2-fold) significantly the fluorescence of the probe DCFH2-DA,
that is indicative of intracellular ROS formation. Free radical generation detected with the probe dihydrorhodamine 123
(DHR 123) was enhanced after oxidative stress, chemical ischemia or hypoglycemia (about 2-fold). Nevertheless, the
antioxidants vitamin E or idebenone were ineffective against intracellular ROS generation. Cellular energy charge
decreased greatly after chemical ischemia, was moderately affected after hypoglycemia, but no significant changes were
observed after oxidative stress. Preincubation with vitamin E prevented the changes in energy charge upon 6 h
posthypoglycemia. We can conclude that irreversible changes occurring during chemical ischemia mainly reflect the
alterations taking place at the ischemic core, whereas hypoglycemia situations may reflect changes occurring at the
penumbra area, whereby vitamin E or idebenone may help to increase cell survival, exerting a beneficial neuroprotective
effect. © 1999 Elsevier Science Inc.
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INTRODUCTION
During ischemia, a massive depletion of glucose and
oxygen occurs, inducing the formation of a severe isch-
emic region characterized by irreversible neuronal dam-
age, the ischemic core. The pathogenesis of cerebral
ischemia has been associated with depletion of cellular
energy sources, a massive release of excitatory amino
acids, mitochondrial dysfunction and formation of reac-
tive oxygen species, that contribute to the oxidative
damage [1]. The brain area surrounding the ischemic
core, the penumbra area, is characterized by a decrement
in glucose supply and further neurodegeneration result-
ing from hypoglycemia. The study of neurochemical
changes derived from hypoglycemia are extremely im-
portant because cell brain injury may not be as irrevers-
ible as in the ischemic core. Under this perspective,
Nehlig [2] reviewed that only severe hypoglycemia de-
creased cerebral glucose utilization. During chronic hy-
poglycemia, the brain “adapted” through a normal cere-
bral function [3] and the maintenance of glucose
utilization at normal levels [2].
Many studies have determined the neuronal damage
occurring after a short or acute situation of hypoglyce-
mia/ischemia. Hypoxia and glucose deprivation, resem-
bling changes that occur during ischemia, reduced the
ATP levels and induced the release of [3H]dopamine by
a Ca21-independent manner [4]. Chemical ischemia also
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increased the release of endogenous amino acids and
highly reduced the energy levels in retinal cells in cul-
ture, used as neuronal models [5–7]. However, the re-
covering processes or the continual exposure to hypo-
glycemia situations have been less investigated.
Goldberg and Choi [8] determined the involvement of
N-methyl-D-aspartate (NMDA) receptors activation in
both the acute and delayed neuronal degeneration, al-
though the way the cells died differed on the dependence
of extracellular Ca21. It would be of interest to examine
the progression of neuronal injury that occurred after a
brief interruption of blood flow to the brain and define
the changes associated with cerebral ischemia and reper-
fusion, to identify capable therapies that would modify
the extent of neuronal damage. Such an investigation
seems to be highly important in the clinic, because if the
flow interruption is not reversed during the first hour, the
cells within the most severely ischemic region will inev-
itably die [1]. Because there is a narrow therapeutical
window after cerebral ischemia to reverse or interfere
with the progression of neuronal damage, the search for
effective agents capable of reducing the progression of
neuronal injury occurring after ischemia further supports
the research. According to this purpose, the present study
was undertaken to determine the effectiveness of several
agents, including antioxidants, in alleviating cell injury
that followed the withdrawal of metabolic inhibitors, to
mimic neuronal reperfusion after situations of hypoxia,
hypoglycemia or ischemia.
Thus, we determined the contribution of ROS gen-
eration to cell injury after the depletion of cellular
energy sources in the presence of metabolic inhibitors,
by using retinal cells in culture as a neuronal model.
We evaluated retinal cell injury induced by oxidative
stress, chemical hypoxia, hypoglycemia or ischemia
and analyzed the formation of endogenous peroxides
and other ROS. The lypophilic antioxidants, vitamin E
and idebenone, a noncompetitive antagonist of the
NMDA receptors, MK-801 [(1)-5-methyl-10,11-dihy-
dro-5H-dibenzo[a,d]-cyclohepten-5,10-imine hydro-
gen maleate], a blocker of L-type Ca21 channels, ni-
trendipine and an inhibitor of NOS, nitroG-w-arginine,
were tested in their capacity to reduce cell injury
induced by energy depleting conditions, after chemical
ischemia or hypoglycemia, and further compared to
oxidative stress, induced with ascorbate/Fe21. The
present work seems to have a fundamental importance
in providing evidence that increased oxidative mem-
brane damage upon metabolic dysfunction can con-
tribute to decrease neuronal recovery, that may be
reverted in the presence of antioxidants. Vitamin E
and idebenone seem to be particularly important in
reducing cell injury induced by moderate energy de-
pleting conditions associated with ROS formation,
under hypoglycemia situations.
MATERIALS AND METHODS
Materials
Basal Medium of Eagle (Earle’s salts-BME) was pur-
chased from Sigma (St. Louis, MO, USA), trypsin from
GIBCO (UK) and fetal calf serum from BioChrom KG
(Berlin, Germany). The diacetate form of DCFH2, 29,79-
dichlorodihydrofluorescein (DCFH2-DA) and dihydror-
hodamine 123 (DHR 123) were obtained from Molecular
Probes Inc. (Eugene, OR, USA). DCFH2-DA was dis-
solved in methanol at 10 mM and kept under nitrogen, in
the dark, at 220°C until use. DHR 123 stock (5 mM)
was made in DMSO and stored at 220°C. Vitamin E
(D-a-tocopherol) succinate was obtained from Sigma
Chemical Co., MO, USA. Idebenone was a kind gift of
Seber, Portugal. MK-801 ((1)-5-methyl-10,11-dihydro-
5H-dibenzo[a,d]-cyclohepten-5,10-imine hydrogen mal-
eate) was a kind gift of Merck Sharp and Dohme (West
Point, PA, USA). Nitrendipine was obtained from San-
doz Laboratories, Switzerland. All other reagents were of
analytical grade.
Culture of chick retinal cells
Retinal cells were prepared from 8-day-old chick em-
bryos, as described previously [5,6,9,10]. The retinas were
dissociated with trypsin in a Ca21/Mg21-free Hank’s bal-
anced salt solution for 15 min, at 37°C. The digested tissue
was centrifuged and the pellet was resuspended in BME
medium, buffered with 25 mM Hepes and 25 mM
NaHCO
3
, and supplemented with 5% fetal calf serum (heat
inactivated), penicillin (100 units/ml) and streptomycin
(100 mg/ml). The cells were plated at a density of 0.76 3
106 cell/cm2 on poly-L-lysine (0.1 mg/ml) coated glass
coverslips for fluorescence measurements or at a density of
2.09 3 106 cells/cm2 on Costar 12-multiwell plates for
other measurements. Cells were cultured for 6 days at 37°C
in an atmosphere of 95% air and 5% CO2. The culture
medium of cells plated at a higher density was changed
every two days. Similar cultures of retinal cells were pre-
viously described to be highly enriched in amacrine neuron-
like cells [11,12]. These cultures also contain neurons re-
sembling bipolar cells [9] and glial cells.
Induction of oxidative stress or metabolic inhibition
The reaction of retinal cells with inducers of oxidative
stress or metabolic dysfunction was performed similarly
as described previously [5,6], in a Na1 saline solution,
containing (in mM): NaCl 140.0, KCl 5.0, CaCl2 1.5,
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MgCl2 1.0, NaH2PO4 1.0, glucose 5.6 and Hepes 20.0, at
pH 7.4. Briefly, the BME medium was removed, the cells
were washed and allowed to equilibrate in the saline
solution for 10–15 min. Then, they were incubated, for
15 min (37°C), with 5 mM ascorbate/100 mM Fe21 (pH
6.5) to induce oxidative stress, with 5 mg/ml oligomycin
(OL) and 2 mM sodium cyanide (CN) to induce hypoxia
(inhibition of mitochondrial function), with 0.5 mM io-
doacetic acid (IAA) to induce hypoglycemia (inhibition
of glycolysis), or with both hypoxia and hypoglycemia
inducers (OL 1 CN 1 IAA) to induce chemical isch-
emia. Control conditions were carried out in Na1 saline
solution, in the absence of the chemicals, at pH 7.4, for
15 min. After rinsing the cells with Na1 solution, the
experiment was followed by a postincubation of retinal
cells in serum-free BME medium buffered with 25 mM
Hepes and 25 mM NaHCO3, at neutral pH, up to 24 h, at
37°C, in an atmosphere of 5% CO2 and 95% air. The
chemical inducers were only present during the 15 min-
reaction. The withdrawal of metabolic inhibitors was
used as an experimental approach to mimic reperfusion
after situations of hypoxia, hypoglycemia or ischemia,
and compared with similar procedure after cellular
oxidation.
In some experiments the cells were supplemented
with 20 mM vitamin E succinate or 10 mM idebenone,
for 20 h, added to the BME culture medium containing
fetal calf serum, before the reaction with the chemical
inducers (preincubation). In other experiments, the anti-
oxidants (vitamin E or idebenone) were incubated after
the 15 min-reaction, in BME medium without serum, for
up to 12 h (postincubation). When analyzing the effect of
pre- or postincubation of the vitamin E or idebenone, the
induction of oxidative stress or hypoglycemia-like con-
ditions was carried out in the absence of the antioxidants.
The antioxidants were also incubated before, during and
after the induction of chemical ischemia (pre/postincu-
bation). When present, 1 mM MK-801, 2 mM nitrendip-
ine or 500 mM nitroG-w-arginine were present during the
induction of oxidative stress and metabolic inhibition
and were present during the postincubation period, up to
12 h. Under certain conditions, MK-801 (1 mM) was also
incubated in Na1 saline solution without Mg21, for up to
12 h postincubation.
Analysis of cell injury
Retinal cell injury was quantitatively assessed by mea-
suring lactate dehydrogenase (LDH) released from dam-
aged cells into the extracellular medium during the postin-
cubation, monitored from samples recovered from 1 h and
up to 12 or 24 h, after induction of oxidative stress, hypo-
glycemia or ischemialike conditions. Assessment to intra-
cellular LDH was performed after freezing the cells, at
220°C. Cellular debris in both aliquots (intra and extracel-
lular) were removed by centrifugation at 15,200 3 g, for 2
min. Lactate dehydrogenase activity was determined spec-
trophotometrically, by following the rate of conversion of
NADH to NAD1 at 340 nm, according to Bergmeyer and
Brent [13]. Lactate dehydrogenase leakage was expressed
as a % of total activity (% of LDH released 5 extracellular
LDH/extracellular LDH 1 intracellular LDH).
Monitoring ROS generation
Reactive oxygen species (ROS) were measured by
following the oxidation of DCFH2 to the fluorescent
DCF, that detects the formation of intracellular perox-
ides, as described previously [14–16]. Free radical gen-
eration was also monitored by following the oxidation of
DHR 123, an oxidation-sensitive indicator that, when
oxidized to the positively charged fluorescent derivative
rhodamine 123 (RH 123), it moves to the inside-negative
mitochondrial environment, being suggested as a probe
to measure mitochondrial ROS production [17], namely
superoxide [18], hydrogen peroxide [15] and peroxini-
trite [19].
After the reaction for 15 min and postincubation for 2
or 6 h in BME without serum, the retinal cells were
washed twice and loaded, in the dark, with 20 mM
DCFH2-DA in Na1 saline solution, at pH 7.4, for 20
min, at 37°C. Loading of the probe was renewed for each
experiment. After rinsing, cell fluorescence was mea-
sured in Na1 medium, at pH 7.4 (37°C), with excitation
at 502 nm and emission at 550 nm, using a SPEX
Fluorolog spectrometer equipped with a thermostated
waterbath. The increments of fluorescence, due to the
oxidation of DCFH2 to DCF, were recorded for 15 min,
and expressed as arbitrary units above the initial values.
Similarly, treated retinal cells, post-incubated for 2 or
6 h in serum free BME, were washed with Na1 saline
solution and loaded with 5 mM DHR 123 in Na1 saline
solution, pH 7.4. Fluorescence was recorded for 60 min,
at 37°C, to allow the probe to equilibrate between the
intracellular and extracellular compartments and to
maintain a steady-state intracellular concentration of
DHR 123. Cell fluorescence was measured with excita-
tion at 500 nm and emission at 536 nm, by using a SPEX
Fluorolog spectrometer. Rhodamine fluorescence incre-
ments were expressed as arbitrary units above the initial
values.
Determination of cellular energy charge
The adenine nucleotides (ATP, ADP and AMP) were
measured after removal of the incubation medium and
cell extraction with 0.3 M perchloric acid (0–4°C).
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Then, the cells were recovered and centrifuged at
15,800 3 g, for 5 min. The pellets were used to deter-
mine the protein content by the Sedmak method [20],
whereas the supernatants were neutralized with 10 M
KOH/5 M Tris and centrifuged at 15,800 3 g for 10 min.
The resulting supernatants were analyzed by separation
in a reverse-phase HPLC, as described by Stocchi et al.
[21]. The chromatographic apparatus used was a Beck-
man-System Gold, consisting of a 126 Binary Pump
Model, a 166 Variable UV detector and a Lichrospher
100 RP-18 (5 mm) column, from Merck (Darmstadt,
Germany). The samples were eluted with 100 mM
KH2PO4 buffer, at pH 7.4, and 1% methanol, at a flow
rate of 1.2 ml/min. ATP, ADP and AMP were detected at
254 nm, for 6 min. The energy charge (EC) of retinal
cells was calculated according to Atkinson [22], as fol-
lows: EC 5 (ATP 1 0.5 ADP)/(ATP 1 ADP 1 AMP).
Statistical analysis
Data were expressed as the means 6 SEM of the
indicated number of experiments. The measurements
were statistically analyzed using the unpaired two-tailed
Student’s t-test for the comparison of the means of two
Gaussian populations or the one-way ANOVA Tukey
post-test for multiple comparisons (p , .05 was consid-
ered significant).
RESULTS
Time-dependent changes in retinal cells viability after
oxidative stress, chemical hypoxia, hypoglycemia or
ischemia
Figure 1 shows the time-dependent changes in retinal
cells viability induced by oxidative stress, chemical hyp-
oxia, hypoglycemia or ischemia, as determined by the
release of LDH. Chemical hypoxia, induced by inhibit-
ing both ATP synthase and cytochrome c oxidase, did
not significantly affect cell viability up to 24 h postincu-
bation, in comparison with the controls (Fig. 1). Oxida-
tive stress, previously shown to exacerbate the oxidation
of retinal cells [10,23], increased significantly LDH leak-
age 1 h after the reaction with ascorbate/Fe21 (3.44 6
0.28%, p , .01, as compared to the controls). Loss of
cell viability induced by cellular oxidation stabilized
after approximately 6 h (10.34 6 0.82% LDH released,
Figs. 1 and 2). Significative changes in retinal cell via-
bility evoked by hypoglycemia-like conditions, that
evolve the inhibition of the glycolytic enzyme glyceral-
dehyde 3-phosphate dehydrogenase, occurred later as
compared to oxidized conditions, upon 4 h (4.74 6
0.72% LDH, p , .05), as shown in Figs. 1 and 3. A
major reduction in cell viability was observed 10 h after
exposure to IAA (21.42 6 1.05% of LDH leakage).
Retinal cell injury induced by chemical ischemia, in the
presence of both hypoxia and hypoglycemia inducers,
occurred upon 2 h (3.07 6 0.79%, p , .05), after
oxidative stress and before hypoglycemia increments in
LDH leakage (Figs. 1 and 4). Although the release of
LDH upon ischemia occurred at a slower rate as com-
pared to hypoglycemia, up to about 10 h, ischemia in-
duced a major decrement in cell viability, from 12 h and
up to 24 h (Fig. 1). Upon 24 h, chemical ischemia
induced the release of 42.83 6 3.39% LDH, indicative of
toxic effects induced by the metabolic inhibitors. After
15 min exposure to inducers of oxidative stress, chemical
hypoxia or ischemia, no significant changes in LDH
leakage were observed, as compared to non-treated (con-
trol) retinal cells [5].
Effect of MK-801, nitrendipine and nitroG-w-arginine
on retinal cell viability after chemical ischemia,
hypoglycemia or oxidative stress
Ischemia situations and metabolic dysfunction have
also been associated with a massive release of excitatory
amino acids, an increase in intracellular Ca21 concentra-
tion and the activation of NOS [5,24–26]. Thus, we
analyzed whether the antagonist of the NMDA glutamate
Fig. 1. Comparison of retinal cell injury after oxidative stress, hypoxia,
hypoglycemia or ischemialike conditions. Oxidative stress, hypoxia,
hypoglycemia or ischemia were induced for 15 min, at 37°C, in the
presence of the 5 mM ascorbate/100 mM Fe21, pH 6.5 (Oxidized), 5
mg/ml OL 1 2 mM CN, 0.5 mM IAA, or 5 mg/ml OL 1 2 mM CN 1
0.5 mM IAA, respectively. Control cells were incubated in Na1 saline
solution without chemical inducers, for 15 min. After rinsing, the
retinal cells were incubated with BME without serum, up to 24 h, at
37°C. The extracellular medium was recovered after 1, 2, 4, 6, 8, 10, 12
and 24 h to determine the activity of LDH. Retinal cell injury was
evaluated as a function of the increase in LDH leakage. Data are the
means 6 SEM of triplicates from 7–11 experiments.
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receptors, MK-801 (1 mM), a blocker of L-type Ca21
channels, nitrendipine (2 mM), or an inhibitor of NOS
activity, nitroG-w-arginine (500 mM), caused significa-
tive alterations in retinal cell injury induced by oxidative
stress, chemical ischemia or hypoglycemia. MK-801 was
previously shown to decrease the response to the activa-
tion of the NMDA receptors in retinal cells in culture [9].
By using nitrendipine [Ca21]i changes, in response to
activation of ionotropic glutamate receptors [27] or upon
K1-depolarization [28], were previously shown to in-
volve the L-type Ca21 channels in retinal cells in culture.
Furthermore, we showed that nitroG-w-arginine de-
creased the activity of NOS in retinal cells in culture [29]
by decreasing the conversion of citrulline from arginine.
Nevertheless, retinal cell injury induced by oxidative
stress, chemical ischemia or hypoglycemia was not sig-
nificantly affected after incubation with MK-801, nitren-
dipine or nitroG-w-arginine (Table 1). Significative pro-
tective data were only observed at 4 h posthypoglycemia
in the presence of MK-801 or nitrendipine (p , .05) or
at 4 h postischemia in the presence of MK-801 (p , .05),
as shown in Table 1. Incubation with MK-801 (1 mM) in
Fig. 2. Oxidative stress-induced retinal cell injury. Influence of vitamin
E or idebenone. Retinal cells were incubated in the presence of 5 mM
ascorbate/100 mM Fe21, at pH 6.5, whereas the controls were incu-
bated in the absence of the oxidant pair, at pH 7.4, for 15 min. Analysis
of LDH leakage after oxidative stress was performed during the postin-
cubation, up to 12 h. Vitamin E (20 mM) or idebenone (10 mM) were
preincubated (Preinc.) for 20 h as a supplement to the culture medium
(A) or were postincubated (Postinc.) in BME medium without serum up
to 12 h (B). Data are the means 6 SEM from 6–11 experiments run
in triplicates. Statistical significance: **p , .01 or ***p , .001
as compared to the control; †p , .05, ††p , .01 or †††p , .001
as compared to oxidative stress conditions in the absence of the
antioxidants.
Fig. 3. Hypoglycemia-induced retinal cell injury. Influence of vitamin
E or idebenone. The cells were incubated in the presence of 0.5 mM
IAA, for 15 min. The controls were incubated in the absence of IAA.
The analysis of LDH leakage was performed during the postincubation,
up to 12 h. Vitamin E (20 mM) or idebenone (10 mM) were pre-
incubated (Preinc.) for 20 h as a supplement to the culture medium (A)
or were postincubated (Postinc.) in BME medium without serum, up to
12 h (B). Data are the means 6 SEM of triplicates from six to seven
experiments. Statistical significance: ***p , .001 as compared to the
control; †p , .05, ††p , .01 or †††p , .001 as compared to hypo-
glycemia (IAA)-like conditions in the absence of the antioxidants.
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Na1 medium without Mg21, but containing Ca21, for 15
min plus 12 h postincubation, did not influence signifi-
cantly the release of LDH (not shown). These results
suggested that the activation of NMDA receptors, the
entry of Ca21 through the L-type Ca21 channels or the
activation of NOS may not be highly involved in delayed
retinal cell injury induced by oxidative stress or meta-
bolic inhibition.
Effect of antioxidants, vitamin E and idebenone, on
retinal cell viability after chemical ischemia,
hypoglycemia or oxidative stress
Because neuronal injury occurring after ischemia/
reperfusion has been associated with the formation of
reactive oxygen species [30,31], we evaluated the effect
of the antioxidants, vitamin E and idebenone, on the
release of LDH induced by oxidative stress or metabolic
dysfunction situations exacerbated by inducers of hypo-
glycemia or ischemia, up to 12 h (Figs. 2–4). Vitamin E
succinate was previously shown to decrease the extent of
lipid peroxidation induced by ascorbate/Fe21 in retinal
cells in culture [23,32].
After a preincubation (Fig. 2A), vitamin E and ide-
benone efficiently reduced oxidative stress-induced cell in-
jury to levels similar to control retinal cells (Fig. 2A). We
also tested the hypothesis that postincubation of the anti-
oxidants prevented retinal cell damage. Figure 2B shows
vitamin E-mediated decrease (p , .05) of retinal cell injury
induced by oxidative stress, from 2 h and up to 12 h
postincubation. Major differences induced by vitamin E
were observed upon 6 h postincubation (about 1.7-fold
decrease in LDH leakage). We also analyzed the effect of
idebenone postincubation, that decreased cell injury in-
duced by oxidized conditions, but only during the first 2–6
h (about 3 to 1.5-fold decrease in LDH release). Vitamin E
and idebenone were less protective upon postincubation
(Fig. 2B) than upon preincubation (Fig. 2A). Incubation of
vitamin E or idebenone before, during and after exposure to
ascorbate/Fe21 showed similar results as compared to those
found in Fig. 2A (not shown).
After hypoglycemialike conditions, preincubation of
vitamin E was also very effective in reducing retinal cell
injury (Fig. 3A) up to 12 h postincubation (2.7-fold
decrease in LDH release). Although significant, preincu-
bation of idebenone (10 mM) reduced LDH leakage by
only 1.3-fold (Fig. 3A). Postincubation of idebenone was
slightly more efficient than vitamin E in reducing the
release of LDH after hypoglycemia-like conditions (Fig.
3B). Upon 12 h postincubation, vitamin E decreased
IAA-induced retinal cell injury by about 1.2-fold
(16.66 6 0.91% LDH, p , .05), whereas idebenone
decreased cell injury by about 1.5-fold (13.23 6 1.17%
LDH, p , .01). Exposure to vitamin E or idebenone
before, during and after the reaction with IAA did not
show major effects as compared with the preincubation
(data not shown).
Chemical ischemia-induced retinal cell damage was
not significantly affected upon preincubation of the an-
tioxidants vitamin E or idebenone (Fig. 4A). Because, in
Fig. 4. Ischemia-induced retinal cell injury. Influence of vitamin E or
idebenone. Ischemialike conditions were induced in the presence of 5
mg/ml OL, 2 mM CN and 0.5 mM IAA, for 15 min, at 37°C. Control
retinal cells were incubated in the absence of the inducers. LDH
leakage was measured during the postincubation in BME medium
without serum, up to 12 h. Vitamin E (20 mM) or idebenone (10 mM)
were pre-incubated (Preinc.) for 20 h as a supplement to the culture
medium (A and B). The antioxidants were also incubated prior (20 h),
during (15 min) and at 10 or 12 h after the induction of ischemia, in
BME medium without serum (Pre/postinc. B). Data are the means 6
SEM of triplicates from 6–10 experiments. Statistical significance:
*p , .05 or ***p , .001 as compared to the control; †p , .05, ††p ,
.01 or †††p , .001 as compared to ischemia (OL 1 CN 1 IAA)-like
conditions in the absence of the antioxidants.
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general, postincubation of the antioxidants was less ef-
fective than their preincubation, we tested the protective
effectiveness of a pre- and postincubation (Fig. 4B).
Under such conditions, vitamin E or idebenone de-
creased retinal cell injury induced by chemical ischemia
upon 10 h (reduction of 1.7 or 1.4-fold in LDH release)
and upon 12 h postincubation (reduction of 1.8 or 1.7-
fold in LDH release).
Formation of reactive oxygen species upon exposure to
oxidative stress, chemical ischemia or hypoglycemia
The relative contribution of oxidative stress or chem-
ical hypoxia, hypoglycemia and ischemia to the forma-
tion of intracellular ROS, namely peroxides, in retinal
cells in culture preloaded with the fluorescent probe
DCFH2-DA is shown in Fig. 5 and Table 2. Oxidative
stress or hypoglycemia-like conditions significantly in-
creased the production of intracellular peroxides, respec-
tively, by 1.15-fold or 1.09-fold (Fig. 5) upon 6 h, a time
period during that retinal cell injury was suggested to be
caused by oxidative lesion of membrane components,
due to the effective protection afforded by the antioxi-
dants (Figs. 2 and 3). However, no significant differences
were observed after exposure to hypoxia or ischemia
inducers (Fig. 5). Furthermore, analysis of ROS genera-
tion at 2 h postincubation revealed no significant incre-
ments in DCF fluorescence (Table 2). Preincubation of
vitamin E or idebenone, at conditions that efficiently
reduced retinal cell injury (Fig. 2A and 3A), did not
affect the formation of intracellular peroxides 6 h upon
exposure to inducers of oxidative stress or hypoglycemia-
like conditions (Table 2).
Reactive oxygen species formation was also measured
Fig. 5. Comparison of intracellular peroxides formation after oxidative
stress, hypoxia, hypoglycemia or ischemialike conditions. Intracellular
peroxides or ROS were examined by following the increments in DCF
fluorescence in cells postincubated for 6 h after the induction of
oxidative stress (Ox), hypoxia (Hyp), hypoglycemia (IAA) or isch-
emia-like conditions (Isc), for 15 min. Control (C) retinal cells were
incubated similarly as described, but in the absence of the chemical
inducers. The cells were loaded with DCFH2-DA (20 mM) for 20 min
and the peroxides were recorded for 15 min, at 37°C. Data are the
means from 5–12 measurements. Statistical significance: **p , .01 as
compared to control conditions.
Table 1. Influence of MK-80, Nitrendipine or NitroG-w-Arginine on the Release of LDH Induced by Oxidative Stress, Hypoglycemia or
Ischemialike Conditions
Postincubation (h)
LDH leakage (% of total)
2 h 4 h 6 h 12 h
Control (C) 1.54 6 0.34 1.45 6 0.30 1.42 6 0.30 2.53 6 0.42
C 1 MK-801 0.97 6 0.24 1.19 6 0.26 1.57 6 0.43 1.52 6 0.25
C 1 nitrendipine 0.76 6 0.12 1.69 6 0.29 2.51 6 0.46 1.60 6 0.02
C 1 nitroG-w-arginine 1.07 6 0.14 1.91 6 0.65 2.21 6 0.06 1.65 6 0.05
Oxidative stress (Ox) 4.43 6 0.47 6.03 6 0.53 6.77 6 0.67 7.65 6 0.76
Ox 1 MK-801 3.41 6 0.40 5.08 6 0.55 5.62 6 0.64 6.61 6 0.52
Ox 1 nitrendipine 2.66 6 0.58 4.62 6 0.78 5.57 6 1.14 5.72 6 0.15
Ox 1 nitroG-w-arginine 3.63 6 0.96 4.95 6 1.02 5.04 6 0.82 8.88 6 0.74
Hypoglycemia (IAA) 1.07 6 0.20 5.82 6 0.51 13.62 6 0.99 17.88 6 0.79
IAA 1 MK-801 0.90 6 0.28 3.47 6 0.49* 13.19 6 1.19 18.14 6 0.92
IAA 1 nitrendipine 1.07 6 0.38 4.29 6 0.33* 13.46 6 1.25 16.99 6 0.53
IAA 1 nitroG-w-
arginine
0.96 6 0.29 6.55 6 1.71 15.73 6 0.29 17.95 6 1.05
Ischemia (Isc) 1.10 6 0.26 4.25 6 0.58 11.21 6 1.38 20.74 6 0.94
Isc 1 MK-801 0.76 6 0.20 2.69 6 0.29* 10.30 6 0.70 19.11 6 0.64
Isc 1 nitrendipine 1.40 6 0.40 4.12 6 0.47 10.75 6 0.48 18.98 6 0.70
Isc 1 nitroG-w-arginine 0.92 6 0.16 6.22 6 1.03 17.17 6 1.21 20.08 6 2.19
Retinal cells were incubated in the presence of 5 mM ascorbate and 100 mM Fe21, at pH 6.5 (Oxidative stress-Ox), 0.5 mM IAA (hypoglycemia-
IAA) or ischemia (Isc) inducers (5 mg/ml oligomycin, 2 mM cyanide and 0.5 mM IAA), for 15 min. Control (C) retinal cells were incubated in the
absence of the chemical inducers. The incubation medium was recovered upon 2, 4, 6 or 12 h of postincubation in BME medium without serum and
LDH activity was measured as described under Methods. MK-801 (1 mM), nitrendipine (2 mM) or nitroG-w-arginine (500 mM) were incubated during
and after (up to 12 h) the 15 min reaction. LDH leakage data are the means 6 SEM of duplicates or triplicates from 2–3 independent experiments.
* p , .05 as compared to hypoglycemia or ischemialike conditions in the absence of MK-801, nitrendipine or nitroG-w-arginine.
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with DHR 123 (Fig. 6 and Table 3), a fluorescent probe
shown to be oxidized not only by superoxide and hydro-
gen peroxide [15,18], but also by peroxinitrite [19].
Generation of ROS was detected upon 2 or 6 h (Fig. 6).
At 2 h, induction of oxidative stress, hypoglycemia or
ischemia enhanced significantly the formation of ROS by
about 1.7-fold (Fig. 6A). Upon 6 h postincubation, ROS
production increased significantly after oxidative stress
(1.6-fold) or chemical ischemia (1.8-fold), although we
did not observe significant changes after hypoglycemia-
like conditions (Fig. 6B). We also analyzed the effect of
preincubation of vitamin E and idebenone upon 2 h, due
to the increment in rhodamine fluorescence under all the
experimental conditions (Table 3). The antioxidants were
without effect in reducing ROS formation, measured
with DHR 123, in cultured retinal cells (Table 3).
The formation of TBARS, a common nonspecific
indicator of peroxidation byproducts, resulting from free
radical attack on double bonds of polyunsaturated fatty
acids that comprise membrane phospholipids integrity,
was not detected upon 2 or 6 h after chemical ischemia
or hypoglycemia (not shown), suggesting that an exten-
sive membrane lipid peroxidation was not involved in
retinal cell damage.
Energy charge of retinal cells after exposure to
oxidative stress, chemical ischemia or hypoglycemia
In this study we also evaluated the changes in energy
charge upon 2 or 6 h postincubation, in comparison with the
alterations occurring after 15 min-reaction (0 h postincuba-
tion), as shown previously [5]. Figure 7A shows the energy
charge of oxidized retinal cells in comparison with controls
and cells submitted to chemical ischemia. As demonstrated
previously, oxidative stress did not affect significantly the
energy charge even upon 2 h (0.83 6 0.05) or 6 h (0.91 6
0.03), as compared to the controls or to the results observed
after 0 h postincubation (Fig. 7A). Nevertheless, the energy
Fig. 6. Comparison of ROS formation after oxidative stress, hypogly-
cemia or ischemialike conditions. ROS were analyzed for 60 min by
determining the increment in rhodamine fluorescence intensity with the
probe DHR 123 (5 mM) in retinal cells postincubated for 2 (A) or 6 h
(B) after oxidative stress (Oxidized), hypoglycemia (IAA) or ischemia-
like conditions (OL 1 CN 1 IAA). Data are the means 6 SEM from
three to nine measurements. Statistical significance: *p , .05 or **p ,
.01 as compared with control conditions at 2 or 6 h postincubation.
Table 2. Influence of Vitamin E or Idebenone on the Formation of
Intracellular Peroxides at 2 or 6 h Postincubation after Oxidative
Stress, Hypoglycemia or Ischemialike Conditions
Postincubation (h)
Increment of DCF fluorescence
(AU above the initial values)
2 h 6 h
Control (C) 1.14 6 0.02 (4) 1.08 6 0.03 (8)
C 1 vitamin E 1.15 6 0.03 (6) ND
C 1 idebenone 1.15 6 0.02 (7) ND
Oxidative stress (Ox) 1.18 6 0.07 (7) 1.24 6 0.06 (5)*
Ox 1 vitamin E 1.14 6 0.02 (8) 1.13 6 0.01 (5)
Ox 1 idebenone 1.13 6 0.01 (6) 1.15 6 0.02 (7)
Hypoglycemia (IAA) 1.15 6 0.02 (6) 1.18 6 0.03 (10)*
IAA 1 vitamin E 1.06 6 0.01 (7) 1.13 6 0.03 (5)
IAA 1 idebenone 1.12 6 0.01 (5) 1.13 6 0.03 (6)
Ischemia (Isc) 1.17 6 0.05 (11) 1.14 6 0.02 (12)
Isc 1 vitamin E 1.10 6 0.02 (8) ND
Isc 1 idebenone 1.17 6 0.04 (10) ND
Retinal cells were incubated in the presence of 5 mM ascorbate and
100 mM Fe21, at pH 6.5 (Oxidative stress-Ox), 0.5 mM IAA (Hypo-
glycemia-IAA) or Ischemia (Isc) inducers (5 mg/ml OL, 2 mM CN and
0.5 mM IAA), for 15 min. Control (C) cells were incubated in the
absence of the chemical inducers. The antioxidants vitamin E (20 mM)
or idebenone (10 mM) were pre-incubated in BME culture medium, for
20 h. After 2 or 6 h postincubation in BME medium without serum, the
cells were loaded with DCFH2-DA (20 mM), for 20 min. The fluores-
cence of DCF was monitored for 15 min and the values were expressed
as increments of fluorescence, in arbitrary units (AU) above the initial
values. Data are the means 6 SEM of the number of measurements
indicated in brackets. ND 5 not determined.
* p , .01 as compared with the control in the absence of the
antioxidants.
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charge after chemical ischemia, decreased strongly after 15
min-reaction (0 h postincubation), was maintained upon 2 h
postincubation (0.14 6 0.01) and decreased even further
after 6 h postincubation, to 0.01 6 0.002 (Fig. 7A), that
corresponded to a major decrease of the ATP/ADP ratio
(not shown). Preincubation of the antioxidants vitamin E or
idebenone did not affect the energy charge induced by
oxidized conditions (Fig. 7A) or ischemia (not shown). We
also analyzed the energy charge in cells submitted to hy-
poglycemialike conditions (Fig. 7B). Upon 2 h postincuba-
tion, in cells submitted to hypoglycemia, the energy charge
decreased to 0.53 6 0.08, whereas upon 6 h postincubation
the energy charge decreased to 0.18 6 0.07. Preincubation
with vitamin E or idebenone did not affect the energy
charge observed upon the reaction with IAA, for 15 min, or
on 2 h postincubation. No significant results were observed
in the presence of idebenone upon 6 h postincubation, either
(Fig. 7B). However, upon preincubation with vitamin E the
decrement in energy charge occurring 6 h after incubation
with IAA was reverted to 0.60 6 0.08 (p , .001, as
compared to IAA alone).
DISCUSSION
Over the last decade many studies have provided
evidence that ROS are important contributors to neuronal
injury mediated by ischemia [30,31,33]. In this study, by
using cultured retinal cells as neuronal models, we have
shown that the antioxidants vitamin E and idebenone
afford protection against retinal cell injury mediated by
Fig. 7. Energy charge of retinal cells in culture after exposure to oxidative
stress, hypoglycemia or ischemia-like conditions. Influence of vitamin E
and idebenone. Retinal cells were exposed to inducers of oxidized condi-
tions (ascorbate/Fe21, pH 6.5), hypoglycemia (IAA) or ischemia-like
conditions (OL 1 CN 1 IAA), for 15 min (time 0 h). Postincubation in
BME medium without serum was performed for 2 or 6 h after the reaction.
When present, 20 mM vitamin E or 10 mM idebenone were preincubated
for 20 h as a supplement to the culture medium. (A) Data from oxidative
stress and ischemialike conditions in comparison with control retinal cells.
(B) Data from hypoglycemialike conditions in comparison with the con-
trols. The adenine nucleotides ATP, ADP and AMP were determined by
reverse phase HPLC, after acidic cell extraction followed by neutraliza-
tion. The energy charge (EC) of retinal cells was calculated by using the
formula: EC 5 (ATP 1 0.5 ADP)/(ATP 1 ADP 1 AMP). Data are the
means 6 SEM of triplicates from three to five experiments. Statistical
significance: *p , .05, **p , .01 or ***p9 , .001 as compared to the
control; †††p , .001 as compared to hypoglycemialike conditions in the
absence of antioxidants.
Table 3. Influence of Vitamin E or Idebenone on the Formation of
ROS at 2 or 6 h Postincubation after Oxidative Stress,
Hypoglycemia or Ischemialike Conditions
Postincubation (h)
Increment in Rhodamine Fluorescence
(AU above the initial values)
2 h 6 h
Control (C) 1.41 6 0.04 (7) 1.54 6 0.11 (4)
C 1 vitamin E ND ND
C 1 idebenone ND ND
Oxidative stress (Ox) 2.28 6 0.37 (5)* 2.48 6 0.28 (6)*
Ox 1 vitamin E 2.22 6 0.31 (6)* ND
Ox 1 idebenone 1.99 6 0.26 (6)* ND
Hypoglycemia (IAA) 2.48 6 0.19 (3)† 1.83 6 0.17 (5)
IAA 1 vitamin E 2.76 6 0.31 (3)† ND
IAA 1 idebenone 2.31 6 0.23 (6)* ND
Ischemia (Isc) 2.47 6 0.36 (5)† 2.75 6 0.29 (9)*
Isc 1 vitamin E 2.76 6 0.10 (4)† ND
Isc 1 idebenone 2.75 6 0.17 (3)† ND
Retinal cells were incubated in the presence of ascorbate (5 mM)/
Fe21 (100 mM), pH 6.5 (Oxidative stress-Ox), 0.5 mM IAA (Hypo-
glycemia-IAA) or Ischemia (Isc) inducers (5 mg/ml OL, 2 mM CN and
0.5 mM IAA), for 15 min. Control (C) cells were incubated in the
absence of the inducers. The antioxidants vitamin E (20 mM) or
idebenone (10 mM) were pre-incubated in BME culture medium, for
20 h. After 2 or 6 h post-incubation in BME medium without serum, the
cells were loaded with DHR 123 (5 mM) and the increment in rhoda-
mine fluorescence was monitored for 60 min. Fluorescence data, ex-
pressed in arbitrary units (AU) above the initial values, are the means 6
SEM of the number of measurements indicated in brackets. ND 5 not
determined.
* p , .05 or † p , .01 as compared to the controls in the absence
of the antioxidants.
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oxidative stress or metabolic dysfunction, mainly asso-
ciated with hypoglycemia situations. However, the anti-
oxidants were not very effective against retinal cell in-
jury induced by chemical ischemia, probably associated
with irreversible damage occurring in the ischemic core.
MK-801, nitrendipine and nitroG-w-arginine may not
be highly effective against delayed retinal cell injury
In early studies, we showed that hypoxic and ischemic
conditions, induced in the presence of metabolic inhibi-
tors, increased the release of excitatory amino acids and
increased the [Ca21]i [5]. Under ischemia-like condi-
tions, the release of glutamate was closely associated
with a decrease in cellular ATP [6]. Thus, the extracel-
lular accumulation of glutamate can stimulate the gluta-
mate receptors, namely the NMDA receptor, suggested
to play an important role in neuronal injury [34]. Signif-
icant protection of retinal cells afforded by MK-801, a
noncompetitive antagonist of the NMDA receptors, was
only observed upon 4 h of posthypoglycemia or post-
ischemia (Table 1). MK-801 failed to reduce retinal cell
damage under our experimental conditions, despite used
at low concentrations to allow specific interactions with
the NMDA receptor, maintained during all the experi-
ment and under conditions that induced the opening of
the receptor associated channel, in experiments carried
out in the absence of Mg21 (not shown). Nevertheless,
Steinberg et al. [35] showed previously that MK-801
could be effective as a neuroprotector against focal ce-
rebral ischemia if the dose applied was maintained. Ear-
ley et al. [36] also showed neuroprotective effects of
MK-801 against cortical damage induced by cerebral
ischemia and, in the retina, Zeevalk and Nicklas [37,38]
found protective effects of MK-801 (1 mM) against tox-
icity induced by 30 min-metabolic inhibition.
Nitrendipine, the L-type Ca21 channel blocker, was
not protective against cell injury induced by oxidative
stress or metabolic inhibition either (Table 1). This may
be in accordance with the reduced involvement of
NMDA receptor-mediated injury (Table 1), because the
Ca21 channel antagonists were shown to attenuate neu-
rotoxicity induced by activation of NMDA receptors
[39]. In retinal cells in culture, Duarte et al. [27] showed
that activation of ionotropic glutamate receptors in-
creased [Ca21]i, occurring through the permeation of the
receptor-associated channels and through the voltage-
gated Ca21 channels, namely of the L-type. Moreover,
the L-type Ca21 channels were observed to be highly
affected after K1-depolarization of ascorbate/Fe21-oxi-
dized retinal cells [28].
Increasing evidences suggest the stimulation of neu-
ronal NOS activity during ischemia. Ischemia-induced
damage was substantially reduced in NOS mutants or by
using specific NOS inhibitors [25,40,41]. Inducible NOS
knockouts also reduced the susceptibility to ischemic
brain injury [42]. Moreover, NOS inhibitors protected
against excitotoxic neuronal injury [43]. Although we
found previously that nitroG-w-arginine reduced the ac-
tivity of NOS in retinal cells in culture [29], exposure to
nitroG-w-arginine was not effective against retinal cell
injury up to 12 h upon chemical ischemia, hypoglycemia
or oxidative stress (Table 1). The failure of nitroG-w-
arginine to increase the viability of retinal cells upon
hypoglycemia or ischemia may also be related with a
reduced involvement of the NMDA receptors in cell
injury (Table 1), because the generation of nitric oxide
has been implicated in the excitotoxic neuronal injury
mediated by activation of the NMDA receptors [43,44].
Recently, we showed an inhibition of NOS activity after
15 min ascorbate/Fe21-induced oxidative stress in retinal
cells [29], explaining the inefficacy of the inhibitor of
NOS after withdrawal of the oxidant inducers.
Extensive delayed retinal cell injury after chemical
ischemia
Characterization of time-dependent changes in retinal
cells viability showed that depending on how the cells
are stressed, their vulnerability to mechanisms associated
with cell death may differ. Upon chemical hypoxia there
was a maintenance of cell viability (Fig. 1), probably
resulting from no significant changes in cellular energy
status [5,6] or in the intracellular generation of ROS (Fig.
5), although we observed a significant increase in the
extracellular accumulation of excitatory amino acids [5].
Oxidative stress was previously shown to induce the
extracellular accumulation of endogenous glutamate and
aspartate by a Ca21-dependent pathway [5]. However,
the cellular energy charge was not significantly changed
before or after withdrawal of the oxidant pair (Fig. 7A),
and reduction of cell viability (Fig. 1) may have occurred
as a consequence of ROS generation (Figs. 5 and 6).
Surprisingly, LDH leakage was not further enhanced up
to 6 h postincubation (Figs. 1 and 2), that suggested a
limited source of free radicals generation or the stimula-
tion of endogenous antioxidants. As compared to oxida-
tive stress, a decrement in cell viability occurring after
metabolic inhibition, in the presence of hypoglycemia or
ischemia inducers (Fig. 1), is imposed due to a decrease
in cellular energy charge, that shows a major decrement
upon chemical ischemia (Fig. 7). Consequently, delayed
cell damage, upon 24 h postincubation, was enhanced
after ischemia (Fig. 1). Moreover, the extracellular ac-
cumulation of excitatory amino acids occurring by a
Ca21-independent mechanism was larger upon chemical
ischemia in comparison with hypoglycemia in cultured
retinal cells (unpublished results), and the formation of
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ROS, as detected with DHR 123, occurred also in a large
extent (Fig. 6).
Formation of ROS and protection by vitamin E and
idebenone
In this study, we also evaluated the antioxidant effec-
tiveness of vitamin E and idebenone, to determine the
importance of oxidative membrane damage in retinal cell
injury occurring upon chemical ischemia or hypoglycemia,
and compared with ascorbate/Fe21-induced oxidative
stress. Vitamin E is a potent scavenger of peroxyl radicals
within the membranes [45,46]. The polar a-tocopheryl es-
ters, namely vitamin E succinate, have proven valuable
tools for supplementing a-tocopherol to isolated cells, in-
creasing the resistance of cells to oxidative damage [47].
Previously, we determined that preincubation of 10 mM
vitamin E succinate reduced significantly the release of
LDH, the formation of TBARS and conjugated dienes after
5 mM ascorbate/100 mM Fe21 (pH 6.5)-induced lipid per-
oxidation in retinal cells in culture [23]. Vitamin E was also
shown to protect the neurons from deleterious effects in-
duced by cumene hydroperoxide [48]. Idebenone, a benzo-
quinone derivative, seems to act both as a lipid radical
scavenger and as an electron trapping agent. The antioxi-
dant properties of idebenone were determined by the inhi-
bition of lipid peroxidation through its free radical scaven-
ger activity [49]. Furthermore, the protective effects of
idebenone are also attributed to an improvement in cerebral
energy metabolism [50,51].
In this study we show that the antioxidants vitamin E
and idebenone are highly effective in reducing delayed
retinal cell injury, especially when present before the induc-
tion of oxidative stress or hypoglycemia-like conditions
(Figs. 2 and 3). The large effect of the antioxidants impli-
cated the oxidative cell membrane damage in retinal cell
injury. After oxidative stress or hypoglycemia, intracellular
ROS, detected with the fluorescent probes DCFH2-DA or
DHR123, indicated the formation of ROS (Figs. 5 and 6).
The inhibition of glycolysis during hypoglycemia may ac-
count for a decrease in cellular reducing equivalents and,
consequently, an increased formation of intracellular ROS.
Preincubation of vitamin E was also shown to significantly
increase the energy charge 6 h upon hypoglycemia (Fig.
7B), that may be related with a more effective reduction of
retinal cell injury in the presence of vitamin E (Fig. 3A).
Besides vitamin E and idebenone, the spin trapping agent
a-phenyl-tert-butyl nitrone and an inhibitor of lipid peroxi-
dation were shown to protect neurons against hypoglycemic
injury [52].
Because in vivo, the antioxidants may be administered
after ischemia, we also tested the protection afforded by the
antioxidants when postincubated. Under these conditions,
idebenone was protective after oxidative stress, up to 6 h
(Fig. 2B), but still protected against hypoglycemia-induced
cell injury (Fig. 3B). Postincubation of vitamin E was less
evident in decreasing cell injury mediated by hypoglycemia
(Fig. 3B), but it was still effective in increasing cell viability
upon oxidative stress (Fig. 2B). The effectiveness of postin-
cubation of the antioxidants may assume a major impor-
tance in demonstrating the “therapeutic window” of these
antioxidants required for a clinical application against cell
injury associated with hypoglycemia and oxidative stress,
probably occurring at the edge of the ischemic core. A
significant protective effect of the antioxidants against cell
injury, induced by chemical ischemia, was observed only
upon their maintenance during all the experimental proce-
dure (Fig. 4), that may have resulted from a strong depletion
of energy sources (Fig. 7A) and the formation of ROS at a
large extent (Fig. 6). An increase in fluorescence detected
with DHR 123 seems to indicate the formation of ROS not
only after hypoglycemia, but also after ischemia situations.
Nevertheless, because rhodamine redistributes within the
cell in response to changes in mitochondrial membrane
potential, an increase in fluorescence may also derive from
the release of rhodamine from the quenched environment of
the mitochondrial matrix to the cytoplasm. Non-detectable
formation of ROS upon chemical ischemia, as determined
by following the increases in fluorescence of DCFH2, may
have resulted from a decrease in intracellular pH.
Vitamin E distributes to cellular membranes and is lo-
cated in the mitochondrial fractions and in the endoplasmic
reticulum [45]. Ray and Fariss [53] proposed the accumu-
lation of vitamin E succinate at the level of mitochondria,
where it could exert its antioxidant activity. This could be
one of the explanations for vitamin E-induced increase in
cellular energy levels upon hypoglycemia-like conditions.
Similarly, idebenone incorporates easily in the membranes
and was also proposed to interfere with lipid peroxidation in
brain mitochondria [49]. Neither vitamin E or idebenone
influenced significantly the formation of intracellular ROS
(Table 2 or 3), that may be explained by scavenging prop-
erties of these lipophilic antioxidants at the membrane level
and not in the aqueous medium, where oxidation of DCFH2
or DHR 123 takes place. Nevertheless, the antioxidants
vitamin E and idebenone were previously shown to protect
against glutamate-induced cytotoxicity and reduced the for-
mation of intracellular peroxides, as determined with the
probe 29,79-dichlorofluorescin-diacetate [54].
There is compelling evidence that ROS are generated
after ischemia [30,31,33], that may constitute the basis to
explain the enhancement in brain injury that occurs in the
hours after the ischemic onset. Under ischemia, gluta-
mate-mediated generation of mitochondria free radicals
was also shown to occur, that decreased after glutamate
receptor blockade [55]. The injury induced by reoxygen-
ation after hypoxia was reduced by superoxide dis-
mutase, catalase, trolox and a-tocopherol, indicating the
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occurrence of lipid peroxidation [56]. Thus, the antioxi-
dants have proven to be good protectors in experimental
stroke models. Synthetic superoxide dismutase/catalase
mimetics, catalytically destroying both superoxide and
hydrogen peroxide, were also shown to protect brain
tissue during a delayed-treatment after the onset of isch-
emia [57]. Recently, the Mn-superoxide dismutase was
demonstrated to play an important role in the mitochon-
dria during ischemia, and the importance of superoxide
formation in inducing impairment of mitochondria func-
tion was made evident [58,59].
In conclusion, although the antioxidants vitamin E
and idebenone did not greatly interfere with retinal neu-
rotoxicity mediated by a severe depletion of energy
sources, in cells submitted to chemical ischemia, they
efficiently decreased the cellular damage evoked by
moderate energy depleting conditions, upon hypoglyce-
mia. This may have important implications for the design
of neuroprotective strategies in clinical therapy, aimed at
combating oxidative damage during and after acute brain
injury, specially associated with the ischemic penumbra
area.
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ABBREVIATIONS
BME—basal medium of Eagle
CN—cyanide
DCFH2—29,79-dichlorodihydrofluorescein
DHR 123—dihydrorhodamine 123
IAA—iodoacetic acid
LDH—lactate dehydrogenase
MK-801—(1)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-
cyclohepten-5,10-imine hydrogen maleate
NMDA—N-methyl-D-aspartate
NOS—nitric oxide synthase
OL—oligomycin
ROS—reactive oxygen species
TBARS—thiobarbituric acid reactive substances
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